Availability of Paracetamol Sold Over the Counter in Europe: A Descriptive Cross-Sectional International Survey of Pack Size Restriction

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Availability of Paracetamol Sold Over the Counter in Europe : A Descriptive Cross-Sectional International Survey of Pack Size Restriction. / Morthorst, Britt Reuter; Erlangsen, Annette; Nordentoft, Merete; Hawton, Keith; Hoegberg, Lotte Christine Groth; Dalhoff, Kim Peder.

I: Basic & Clinical Pharmacology & Toxicology, Bind 122, Nr. 6, 2018, s. 643-649.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Morthorst, BR, Erlangsen, A, Nordentoft, M, Hawton, K, Hoegberg, LCG & Dalhoff, KP 2018, 'Availability of Paracetamol Sold Over the Counter in Europe: A Descriptive Cross-Sectional International Survey of Pack Size Restriction', Basic & Clinical Pharmacology & Toxicology, bind 122, nr. 6, s. 643-649. https://doi.org/10.1111/bcpt.12959

APA

Morthorst, B. R., Erlangsen, A., Nordentoft, M., Hawton, K., Hoegberg, L. C. G., & Dalhoff, K. P. (2018). Availability of Paracetamol Sold Over the Counter in Europe: A Descriptive Cross-Sectional International Survey of Pack Size Restriction. Basic & Clinical Pharmacology & Toxicology, 122(6), 643-649. https://doi.org/10.1111/bcpt.12959

Vancouver

Morthorst BR, Erlangsen A, Nordentoft M, Hawton K, Hoegberg LCG, Dalhoff KP. Availability of Paracetamol Sold Over the Counter in Europe: A Descriptive Cross-Sectional International Survey of Pack Size Restriction. Basic & Clinical Pharmacology & Toxicology. 2018;122(6):643-649. https://doi.org/10.1111/bcpt.12959

Author

Morthorst, Britt Reuter ; Erlangsen, Annette ; Nordentoft, Merete ; Hawton, Keith ; Hoegberg, Lotte Christine Groth ; Dalhoff, Kim Peder. / Availability of Paracetamol Sold Over the Counter in Europe : A Descriptive Cross-Sectional International Survey of Pack Size Restriction. I: Basic & Clinical Pharmacology & Toxicology. 2018 ; Bind 122, Nr. 6. s. 643-649.

Bibtex

@article{3bd61f9eb3c14bc096fd84df676a959e,
title = "Availability of Paracetamol Sold Over the Counter in Europe: A Descriptive Cross-Sectional International Survey of Pack Size Restriction",
abstract = "Due to the risk of hepatotoxicity when excessive amounts of paracetamol are consumed, Poisons Information Centers (PICs) frequently receive paracetamol-related enquiries. This study examined how widely pack size restrictions of paracetamol sold over the counter have been implemented in Europe and also availability of paracetamol through non-pharmacy outlets and their possible associations with frequency of poisoning enquiries. A cross-sectional European multi-centre questionnaire study was performed using a questionnaire to identify the extent and nature of paracetamol pack size restrictions, non-pharmacy outlet sales and the frequency of paracetamol-related enquiries to PICs. In total, 21 European countries participated. All PICs provided telephone hotline services. In 14 (67%) countries, pack size restrictions had been implemented in pharmacies (range: 8–30 g). No significant difference (median difference 0.7%, p-value = 0.36) was found when comparing median frequencies of paracetamol-related enquiries in countries with pack size restriction to countries without restrictions. A significantly lower median frequency of paracetamol-related enquiries was found in countries without non-pharmacy outlet sales compared to those with such sales (median difference 2.2%, p = 0.02). Pack size restrictions on pharmacy sales of paracetamol have been implemented in two-thirds of examined countries. There was no difference in the proportion of paracetamol-related enquiries to PICs among countries with and without pack size restrictions. However, a lower rate of paracetamol-related enquiries was noted in countries where paracetamol was not available in non-pharmacy outlets.",
author = "Morthorst, {Britt Reuter} and Annette Erlangsen and Merete Nordentoft and Keith Hawton and Hoegberg, {Lotte Christine Groth} and Dalhoff, {Kim Peder}",
year = "2018",
doi = "10.1111/bcpt.12959",
language = "English",
volume = "122",
pages = "643--649",
journal = "Basic and Clinical Pharmacology and Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Availability of Paracetamol Sold Over the Counter in Europe

T2 - A Descriptive Cross-Sectional International Survey of Pack Size Restriction

AU - Morthorst, Britt Reuter

AU - Erlangsen, Annette

AU - Nordentoft, Merete

AU - Hawton, Keith

AU - Hoegberg, Lotte Christine Groth

AU - Dalhoff, Kim Peder

PY - 2018

Y1 - 2018

N2 - Due to the risk of hepatotoxicity when excessive amounts of paracetamol are consumed, Poisons Information Centers (PICs) frequently receive paracetamol-related enquiries. This study examined how widely pack size restrictions of paracetamol sold over the counter have been implemented in Europe and also availability of paracetamol through non-pharmacy outlets and their possible associations with frequency of poisoning enquiries. A cross-sectional European multi-centre questionnaire study was performed using a questionnaire to identify the extent and nature of paracetamol pack size restrictions, non-pharmacy outlet sales and the frequency of paracetamol-related enquiries to PICs. In total, 21 European countries participated. All PICs provided telephone hotline services. In 14 (67%) countries, pack size restrictions had been implemented in pharmacies (range: 8–30 g). No significant difference (median difference 0.7%, p-value = 0.36) was found when comparing median frequencies of paracetamol-related enquiries in countries with pack size restriction to countries without restrictions. A significantly lower median frequency of paracetamol-related enquiries was found in countries without non-pharmacy outlet sales compared to those with such sales (median difference 2.2%, p = 0.02). Pack size restrictions on pharmacy sales of paracetamol have been implemented in two-thirds of examined countries. There was no difference in the proportion of paracetamol-related enquiries to PICs among countries with and without pack size restrictions. However, a lower rate of paracetamol-related enquiries was noted in countries where paracetamol was not available in non-pharmacy outlets.

AB - Due to the risk of hepatotoxicity when excessive amounts of paracetamol are consumed, Poisons Information Centers (PICs) frequently receive paracetamol-related enquiries. This study examined how widely pack size restrictions of paracetamol sold over the counter have been implemented in Europe and also availability of paracetamol through non-pharmacy outlets and their possible associations with frequency of poisoning enquiries. A cross-sectional European multi-centre questionnaire study was performed using a questionnaire to identify the extent and nature of paracetamol pack size restrictions, non-pharmacy outlet sales and the frequency of paracetamol-related enquiries to PICs. In total, 21 European countries participated. All PICs provided telephone hotline services. In 14 (67%) countries, pack size restrictions had been implemented in pharmacies (range: 8–30 g). No significant difference (median difference 0.7%, p-value = 0.36) was found when comparing median frequencies of paracetamol-related enquiries in countries with pack size restriction to countries without restrictions. A significantly lower median frequency of paracetamol-related enquiries was found in countries without non-pharmacy outlet sales compared to those with such sales (median difference 2.2%, p = 0.02). Pack size restrictions on pharmacy sales of paracetamol have been implemented in two-thirds of examined countries. There was no difference in the proportion of paracetamol-related enquiries to PICs among countries with and without pack size restrictions. However, a lower rate of paracetamol-related enquiries was noted in countries where paracetamol was not available in non-pharmacy outlets.

U2 - 10.1111/bcpt.12959

DO - 10.1111/bcpt.12959

M3 - Journal article

C2 - 29319222

AN - SCOPUS:85041686715

VL - 122

SP - 643

EP - 649

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

SN - 1742-7835

IS - 6

ER -

ID: 214129517